Thiocyanate and chloride as competing substrates for myeloperoxidase
- PMID: 9359420
- PMCID: PMC1218820
- DOI: 10.1042/bj3270487
Thiocyanate and chloride as competing substrates for myeloperoxidase
Abstract
The neutrophil enzyme myeloperoxidase uses H2O2 to oxidize chloride, bromide, iodide and thiocyanate to their respective hypohalous acids. Chloride is considered to be the physiological substrate. However, a detailed kinetic study of its substrate preference has not been undertaken. Our aim was to establish whether myeloperoxidase oxidizes thiocyanate in the presence of chloride at physiological concentrations of these substrates. We determined this by measuring the rate of H2O2 loss in reactions catalysed by the enzyme at various concentrations of each substrate. The relative specificity constants for chloride, bromide and thiocyanate were 1:60:730 respectively, indicating that thiocyanate is by far the most favoured substrate for myeloperoxidase. In the presence of 100 mM chloride, myeloperoxidase catalysed the production of hypothiocyanite at concentrations of thiocyanate as low as 25 microM. With 100 microM thiocyanate, about 50% of the H2O2 present was converted into hypothiocyanite, and the rate of hypohalous acid production equalled the sum of the individual rates obtained when each of these anions was present alone. The rate of H2O2 loss catalysed by myeloperoxidase in the presence of 100 mM chloride doubled when 100 microM thiocyanate was added, and was maximal with 1mM thiocyanate. This indicates that at plasma concentrations of thiocyanate and chloride, myeloperoxidase is far from saturated. We conclude that thiocyanate is a major physiological substrate of myeloperoxidase, regardless of where the enzyme acts. As a consequence, more consideration should be given to the oxidation products of thiocyanate and to the role they play in host defence and inflammation.
Similar articles
-
Substrates and products of eosinophil peroxidase.Biochem J. 2001 Aug 15;358(Pt 1):233-9. doi: 10.1042/0264-6021:3580233. Biochem J. 2001. PMID: 11485572 Free PMC article.
-
Reaction of myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate.Biochemistry. 1998 Dec 22;37(51):17923-30. doi: 10.1021/bi9818772. Biochemistry. 1998. PMID: 9922160
-
Oxidation of chloride and thiocyanate by isolated leukocytes.J Biol Chem. 1986 Jul 25;261(21):9694-702. J Biol Chem. 1986. PMID: 3015901
-
[Antimicrobial activity of myeloperoxidase from neutrophil peroxisome].Izv Akad Nauk Ser Biol. 2002 May-Jun;(3):266-70. Izv Akad Nauk Ser Biol. 2002. PMID: 12071050 Review. Russian.
-
[Myeloperoxidase from neutrophil peroxisomes].Izv Akad Nauk Ser Biol. 2003 May-Jun;(3):261-5. Izv Akad Nauk Ser Biol. 2003. PMID: 12816056 Review. Russian.
Cited by
-
Melatonin prevents myeloperoxidase heme destruction and the generation of free iron mediated by self-generated hypochlorous acid.PLoS One. 2015 Apr 2;10(3):e0120737. doi: 10.1371/journal.pone.0120737. eCollection 2015. PLoS One. 2015. PMID: 25835505 Free PMC article.
-
Deletion of the lactoperoxidase gene causes multisystem inflammation and tumors in mice.Sci Rep. 2021 Jun 14;11(1):12429. doi: 10.1038/s41598-021-91745-8. Sci Rep. 2021. PMID: 34127712 Free PMC article.
-
The Role of Reactive Species on Innate Immunity.Vaccines (Basel). 2022 Oct 17;10(10):1735. doi: 10.3390/vaccines10101735. Vaccines (Basel). 2022. PMID: 36298601 Free PMC article. Review.
-
The lactoperoxidase system links anion transport to host defense in cystic fibrosis.FEBS Lett. 2007 Jan 23;581(2):271-8. doi: 10.1016/j.febslet.2006.12.025. Epub 2006 Dec 19. FEBS Lett. 2007. PMID: 17204267 Free PMC article.
-
Assessment of serum and synovial fluid MMP-3 and MPO as biomarkers for psoriatic arthritis and their relation to disease activity indices.Rheumatol Int. 2022 Sep;42(9):1605-1615. doi: 10.1007/s00296-022-05159-4. Epub 2022 Jun 16. Rheumatol Int. 2022. PMID: 35708757
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials